ADAR1 Capital Management, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 1,000 shares at $1.55 ($2K) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Open-market purchase of $2k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| INM | BUY | 2026-10-05 | $57K | — | Filing → |
| INM | BUY | 2026-09-16 | $118K | — | Filing → |
| TENX | BUY | 2026-09-08 | $1.6M | — | Filing → |